ADD CONDITION

items per page

Aspercreme with Lidocaine Pain Relieving Creme

Last content change checked dailysee data sync status

Active ingredient
Lidocaine Hydrochloride 4 g/100 g
Other brand names
Drug classes
Amide Local Anesthetic, Antiarrhythmic
Dosage form
Lotion
Route
Topical
Prescription status
OTC (over the counter)
Marketed in the U.S.
Since 2014
Label revision date
May 1, 2024
Active ingredient
Lidocaine Hydrochloride 4 g/100 g
Other brand names
Drug classes
Amide Local Anesthetic, Antiarrhythmic
Dosage form
Lotion
Route
Topical
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Marketed in the U.S.
Since 2014
Label revision date
May 1, 2024
Manufacturer
Chattem, Inc.
Registration number
M017
NDC roots
41167-0582, 41167-0587

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

Aspercreme is a pain-relieving cream that contains 4% lidocaine, a medication that helps to numb the skin and temporarily relieve minor pain. This odor-free formula is designed for maximum strength, making it suitable for various types of discomfort you may experience.

You can use Aspercreme to help alleviate pain in specific areas, providing a soothing effect when you need it most. Its convenient cream form allows for easy application, helping you manage minor aches effectively.

Uses

You can use this medication to temporarily relieve minor pain. It’s designed to help you feel more comfortable when dealing with everyday aches and discomforts. Rest assured, there are no known teratogenic effects (which means it doesn’t cause birth defects) associated with this medication, making it a safer option for those who may be concerned about such risks.

Dosage and Administration

If you are an adult or a child over 12 years old, you should apply a thin layer of the medication to the affected area every 6 to 8 hours. However, make sure not to exceed more than 3 applications within a 24-hour period.

For children who are 12 years old or younger, it’s important to consult a doctor before using this medication. They can provide guidance on the appropriate use and dosage for younger patients. Always follow these instructions carefully to ensure safe and effective treatment.

What to Avoid

You should avoid using this product on puncture wounds, large areas of the body, or on skin that is cut, irritated, or swollen. It's important not to use it for more than one week without consulting your doctor. Additionally, make sure to keep it away from your eyes and mucous membranes, and do not bandage or apply local heat, like heating pads, to the area where you use it. Lastly, do not use this product simultaneously with other topical pain relievers.

Side Effects

You should be aware of some potential side effects when using this product. If your condition worsens, if you notice redness or irritation, or if your symptoms persist for more than seven days or return shortly after improvement, you should stop using the product and consult a doctor.

This product is for external use only and should not be applied to puncture wounds, large areas of the body, or on cut, irritated, or swollen skin. Avoid contact with your eyes and mucous membranes, and do not use it alongside other topical pain relievers. If you are pregnant or breastfeeding, it's best to consult a healthcare professional before use. Always keep this product out of reach of children and pets, and seek medical help immediately if it is swallowed.

Warnings and Precautions

This product is for external use only, so please avoid applying it to puncture wounds, large areas of your body, or on skin that is cut, irritated, or swollen. It’s important to use this product exactly as directed and to read all instructions carefully. Avoid contact with your eyes and mucous membranes, and do not apply heat or bandage the area where you use it. Additionally, do not use it alongside other topical pain relievers.

If your condition worsens, if you notice redness or irritation, or if your symptoms last longer than seven days or return shortly after improvement, stop using the product and consult your doctor. Always keep this product out of reach of children and pets. If swallowed, seek medical help or contact a Poison Control Center immediately.

Overdose

If you or someone else has swallowed too much of a medication, it’s important to seek medical help immediately. You can do this by contacting a Poison Control Center or going to the nearest emergency room. Acting quickly can make a significant difference in the outcome.

Signs of an overdose can vary, but they may include unusual drowsiness, confusion, or difficulty breathing. If you notice any of these symptoms, don’t hesitate to get help right away. Remember, it’s always better to be safe and get checked by a medical professional.

Pregnancy Use

If you are pregnant or breastfeeding, it’s important to consult with a healthcare professional before using this medication. They can provide guidance on whether it’s safe for you and your baby. Always prioritize your health and the health of your child by seeking expert advice.

Lactation Use

If you are pregnant or breastfeeding, it’s important to consult with a healthcare professional before using any medication. This ensures that you understand any potential risks and can make informed decisions about your health and the health of your baby. Always prioritize open communication with your doctor regarding your breastfeeding journey.

Pediatric Use

If you have a child who is 12 years old or younger, it's important to consult with a doctor before using this medication. For children over 12 years and adults, you can apply a thin layer of the product to the affected area every 6 to 8 hours. However, be sure not to exceed three applications within a 24-hour period to ensure safety and effectiveness. Always follow these guidelines to help protect your child's health.

Geriatric Use

While there is no specific information about the use of Aspercreme with Lidocaine Pain Relieving Creme in older adults, it’s important to approach any new treatment with caution. Since the drug insert does not mention dosage adjustments or safety concerns for elderly patients, you should consult with a healthcare professional before using this product. They can help ensure that it is appropriate for your needs and discuss any potential risks or interactions with other medications you may be taking. Always prioritize your health and safety when considering new treatments.

Renal Impairment

If you have kidney problems, it's important to know that the information provided does not include specific guidelines for dosage adjustments, special monitoring, or safety considerations related to renal impairment (kidney issues). This means that there are no tailored recommendations for how your treatment may need to change based on your kidney function.

Always consult your healthcare provider for personalized advice and to ensure that your treatment plan is safe and effective for your specific situation. They can help monitor your kidney health and make any necessary adjustments to your medications.

Hepatic Impairment

If you have liver problems, it's important to know that the drug insert does not provide specific information about dosage adjustments, special monitoring, or precautions for your condition. This means that there are no tailored guidelines for how this medication may affect you if you have hepatic impairment (issues with liver function).

Before starting any new medication, including this one, you should discuss your liver health with your healthcare provider. They can help determine the best approach for your treatment and ensure your safety.

Drug Interactions

It's important to be cautious when using certain medications together. Specifically, you should avoid using this medication at the same time as other topical analgesics (pain-relieving creams or gels applied to the skin). Mixing these products can increase the risk of side effects or reduce their effectiveness.

Always discuss any medications you are taking, including over-the-counter products, with your healthcare provider. They can help ensure that your treatment is safe and effective, and they can provide guidance on how to use your medications properly.

Storage and Handling

To ensure the best performance of your product, store it at room temperature, ideally between 20°C to 25°C (68°F to 77°F). It's important to keep the container tightly closed and protect it from light to maintain its effectiveness. Once you open the container, please remember to discard it after use to ensure safety and prevent contamination. Following these guidelines will help you handle the product safely and effectively.

Additional Information

You should apply this medication topically, which means putting it directly on the skin. For adults and children over 12 years old, apply a thin layer to the affected area every 6 to 8 hours, but do not use it more than three times in a 24-hour period. If the patient is 12 years old or younger, it's important to consult a doctor before use.

FAQ

What is Aspercreme?

Aspercreme is an odor-free pain-relieving cream that contains 4% Lidocaine and is designed to temporarily relieve minor pain.

How should I use Aspercreme?

For adults and children over 12 years, apply a thin layer to the affected area every 6 to 8 hours, not exceeding 3 applications in a 24-hour period. For children 12 years and younger, consult a doctor.

Are there any contraindications for using Aspercreme?

Do not use Aspercreme on puncture wounds, large areas of the body, or on cut, irritated, or swollen skin. Avoid using it for more than one week without consulting a doctor.

What should I do if I experience side effects?

Stop using Aspercreme and consult a doctor if your condition worsens, if redness or irritation develops, or if symptoms persist for more than 7 days.

Can I use Aspercreme if I am pregnant or breastfeeding?

If you are pregnant or breastfeeding, ask a health professional before using Aspercreme.

What precautions should I take when using Aspercreme?

Use Aspercreme only as directed, avoid contact with eyes and mucous membranes, do not bandage or apply local heat to the area, and do not use it at the same time as other topical analgesics.

How should I store Aspercreme?

Store Aspercreme at room temperature, between 20°C to 25°C (68°F to 77°F), protect it from light, and keep the container tightly closed.

What should I do if Aspercreme is swallowed?

Keep Aspercreme out of reach of children and pets. If swallowed, seek medical help or contact a Poison Control Center immediately.

Packaging Info

Below are the non-prescription pack sizes of Aspercreme with Lidocaine Pain Relieving Creme (lidocaine hydrochloride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Aspercreme with Lidocaine Pain Relieving Creme.
Details

Drug Information (PDF)

This file contains official product information for Aspercreme with Lidocaine Pain Relieving Creme, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

Aspercreme is an odor-free pain-relieving cream formulated with 4% lidocaine, providing maximum strength relief. The product is presented in a net weight of 2.7 oz (76.5 g).

Uses and Indications

This drug is indicated for the temporary relief of minor pain.

There are no teratogenic effects associated with this drug. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

For adults and children over 12 years of age, a thin layer of the medication should be applied to the affected area every 6 to 8 hours. The total number of applications must not exceed 3 times within a 24-hour period.

For children 12 years and younger, it is advised to consult a physician before use.

Contraindications

Use of this product is contraindicated in the following situations:

Application on puncture wounds is prohibited due to the risk of infection and delayed healing. It should not be applied to large areas of the body or on cut, irritated, or swollen skin, as this may exacerbate the condition or lead to systemic absorption. Prolonged use beyond one week without medical consultation is contraindicated to prevent potential adverse effects.

Additionally, contact with the eyes and mucous membranes must be avoided to prevent irritation or injury. Bandaging or applying local heat, such as heating pads, to the area of use is not recommended, as this may increase absorption and risk of side effects. Concurrent use with other topical analgesics is also contraindicated to avoid potential interactions and increased risk of adverse reactions.

Warnings and Precautions

For external use only. This product is contraindicated for application on puncture wounds, large areas of the body, or on cut, irritated, or swollen skin. It is advised that this product not be used for more than one week without consulting a healthcare professional.

When utilizing this product, it is imperative to adhere strictly to the provided directions. Users should read and follow all instructions and warnings on the packaging. Care should be taken to avoid contact with the eyes and mucous membranes. Additionally, the area of application should not be bandaged or subjected to local heat, such as heating pads. Concurrent use with other topical analgesics is not recommended.

Patients should discontinue use and seek medical advice if any of the following occur: worsening of the condition, presence of redness, development of irritation, or if symptoms persist for more than seven days or resolve only to recur within a few days.

This product should be kept out of reach of children and pets. In the event of ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center should be made without delay.

Side Effects

Patients using this product may experience various adverse reactions. It is important to stop use and consult a healthcare professional if any of the following occur: worsening of the condition, presence of redness, development of irritation, or if symptoms persist for more than 7 days or resolve and then recur within a few days.

This product is intended for external use only. It should not be applied to puncture wounds, large areas of the body, or on cut, irritated, or swollen skin. Additionally, it should not be used for more than one week without consulting a doctor.

While using this product, patients should adhere strictly to the directions provided. Care should be taken to avoid contact with the eyes and mucous membranes. Bandaging or applying local heat, such as heating pads, to the area of use is not recommended. Furthermore, this product should not be used concurrently with other topical analgesics.

For pregnant or breastfeeding individuals, it is advised to seek guidance from a healthcare professional prior to use. It is also crucial to keep this product out of reach of children and pets. In the event of ingestion, immediate medical assistance should be sought or contact with a Poison Control Center should be made.

Drug Interactions

Concurrent use of this medication with other topical analgesics is contraindicated. The combination may increase the risk of adverse effects without providing additional therapeutic benefit. It is advised to avoid using multiple topical analgesics simultaneously to ensure patient safety and optimal therapeutic outcomes. Monitoring for any signs of increased local irritation or systemic effects is recommended if there is a concern about overlapping therapies.

Packaging & NDC

Below are the non-prescription pack sizes of Aspercreme with Lidocaine Pain Relieving Creme (lidocaine hydrochloride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Aspercreme with Lidocaine Pain Relieving Creme.
Details

Pediatric Use

Pediatric patients 12 years and younger should consult a healthcare professional before use. For adolescents and children over 12 years, the recommended dosage is to apply a thin layer to the affected area every 6 to 8 hours, with a maximum of 3 applications within a 24-hour period.

Geriatric Use

There is no specific information regarding the use of Aspercreme with Lidocaine Pain Relieving Creme in geriatric patients. The prescribing information does not provide details on dosage adjustments, safety concerns, or special precautions that may be necessary for elderly patients.

Healthcare providers should exercise caution when administering this product to geriatric patients, considering the absence of data specific to this population. Monitoring for any adverse effects or unusual responses is advisable, given the variability in drug metabolism and sensitivity that may occur in older adults.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully considered in these populations to ensure the safety of both the mother and the fetus or infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is no specific data available regarding the excretion of this medication in breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating mothers.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved, and healthcare providers should be prepared to assess and manage these symptoms accordingly.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous monitoring and evaluation are recommended to ensure patient safety and effective resolution of any complications arising from the overdosage.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children and pets to prevent accidental ingestion or exposure. Instruct patients that if the product is swallowed, they should seek medical help or contact a Poison Control Center immediately.

It is essential for patients to use the product only as directed. They should read and follow all directions and warnings provided on the carton to ensure safe and effective use. Providers should emphasize the importance of avoiding contact with the eyes and mucous membranes, as this could lead to irritation or injury.

Patients should also be informed not to bandage or apply local heat, such as heating pads, to the area of use, as this may increase the risk of adverse effects. Additionally, healthcare providers should counsel patients against using this product simultaneously with other topical analgesics to avoid potential interactions or increased side effects.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored at room temperature, specifically within the range of 20°C to 25°C (68°F to 77°F). It is essential to protect the product from light exposure to ensure its stability. Additionally, once opened, the product should be discarded to prevent any potential degradation or contamination.

Additional Clinical Information

The medication is administered topically. For adults and children over 12 years, a thin layer should be applied to the affected area every 6 to 8 hours, with a maximum of three applications within a 24-hour period. For children aged 12 years and younger, it is advised to consult a doctor before use.

No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Aspercreme with Lidocaine Pain Relieving Creme, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Aspercreme with Lidocaine Pain Relieving Creme, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.